Techcyte
Company

Last deal

$8.4M

Amount

Venture - Series Unknown

Stage

22.12.2023

Date

4

all rounds

$35.4M

Total amount

General

About Company
Techcyte is a leading clinical pathology and diagnostics platform.

Industry

Sector :

Subsector :

Also Known As

Techcyte

founded date

22.07.2013

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company offers a cloud-based, SaaS solution that is HIPAA compliant and CE marked, supporting tests across various areas such as hematology, cytology, bacteriology, and parasitology. Techcyte's clinical digital pathology platform is designed to provide efficiency and accuracy for human, veterinary, and environmental clinics and labs. With integrated AI tools and custom workflows, labs can benefit from digital diagnostics, storage, big data analysis, tumor boards, pharma, and research.
Contacts

Social url